• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

作者信息

Mune T, Rogerson F M, Nikkilä H, Agarwal A K, White P C

机构信息

Division of Pediatric Endocrinology, University of Texas Southwestern Medical Center, Dallas 75235-9063, USA.

出版信息

Nat Genet. 1995 Aug;10(4):394-9. doi: 10.1038/ng0895-394.

DOI:10.1038/ng0895-394
PMID:7670488
Abstract

The syndrome of apparent mineralocorticoid excess (AME) is an inherited form of human hypertension thought to result from a deficiency of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD). This enzyme normally converts cortisol to inactive cortisone and is postulated to thus confer specificity for aldosterone upon the mineralocorticoid receptor. We have analysed the gene encoding the kidney isozyme of 11 beta HSD and found mutations on both alleles in nine of 11 AME patients (eight of nine kindreds). These mutations markedly affect enzymatic activity. They thus permit cortisol to occupy the renal mineralocorticoid receptor and thereby cause sodium retention and hypertension.

摘要

相似文献

1
Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
Nat Genet. 1995 Aug;10(4):394-9. doi: 10.1038/ng0895-394.
2
Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.11β-羟类固醇脱氢酶基因突变导致的人类高血压:表象性盐皮质激素增多症的分子分析
J Hypertens Suppl. 1996 Dec;14(5):S19-24.
3
[A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].[一例由2型11β-羟类固醇脱氢酶缺乏引起的表观盐皮质激素过多症]
Arch Mal Coeur Vaiss. 1997 Aug;90(8):1111-5.
4
11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.11β-羟类固醇脱氢酶与表观盐皮质激素过多综合征
Endocr Rev. 1997 Feb;18(1):135-56. doi: 10.1210/edrv.18.1.0288.
5
Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.11β-羟类固醇脱氢酶的分子分析及其在表观盐皮质激素增多综合征中的作用。
Steroids. 1997 Jan;62(1):83-8. doi: 10.1016/s0039-128x(96)00164-x.
6
11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
Pediatr Res. 1997 Jan;41(1):25-9. doi: 10.1203/00006450-199701000-00004.
7
Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population.阿曼人群中表观盐皮质激素过多综合征的分子基础。
Mol Cell Endocrinol. 2004 Mar 31;217(1-2):143-9. doi: 10.1016/j.mce.2003.10.019.
8
[Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].[11β-羟类固醇脱氢酶缺乏所致表观盐皮质激素过多综合征:对一个智利家族进行19年随访的临床与遗传学研究]
Rev Med Chil. 2000 Jan;128(1):17-26.
9
Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase.
Genomics. 1995 Sep 1;29(1):195-9. doi: 10.1006/geno.1995.1231.
10
A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.与盐皮质激素性高血压相关的2型11β-羟类固醇脱氢酶辅因子结合结构域的突变。
J Clin Endocrinol Metab. 2001 Mar;86(3):1247-52. doi: 10.1210/jcem.86.3.7334.

引用本文的文献

1
Monogenic Hypertension Linked to the Renin-Angiotensin-Aldosterone System.与肾素-血管紧张素-醛固酮系统相关的单基因高血压
Anatol J Cardiol. 2024 Jun 14;28(9):417-28. doi: 10.14744/AnatolJCardiol.2024.4480.
2
Renal Hypokalemia: An Endocrine Perspective.肾性低钾血症:内分泌学视角
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1694-1706. doi: 10.1210/clinem/dgae201.
3
Analysis of clinical factors associated with Kampo formula-induced pseudoaldosteronism based on self-reported information from the Japanese Adverse Drug Event Report database.
基于日本药品不良反应报告数据库的自我报告信息,分析与汉方制剂诱发假性醛固酮增多症相关的临床因素。
PLoS One. 2024 Jan 2;19(1):e0296450. doi: 10.1371/journal.pone.0296450. eCollection 2024.
4
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics.醛固酮增多症:分子遗传学的综合概述。
J Transl Med. 2022 Nov 3;20(1):500. doi: 10.1186/s12967-022-03698-9.
5
Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension.检测尿液外泌体 HSD11B2mRNA 表达:一种用于诊断功能性 11β-HSD2 相关高血压的新工具。
Front Endocrinol (Lausanne). 2021 Aug 23;12:681974. doi: 10.3389/fendo.2021.681974. eCollection 2021.
6
Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess.非经典型醛固酮增多症患者的新型代谢组学特征。
Sci Rep. 2021 Aug 25;11(1):17156. doi: 10.1038/s41598-021-96628-6.
7
Monogenic forms of low-renin hypertension: clinical and molecular insights.单基因形式的低肾素型高血压:临床与分子研究进展。
Pediatr Nephrol. 2022 Jul;37(7):1495-1509. doi: 10.1007/s00467-021-05246-x. Epub 2021 Aug 20.
8
Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice.肾脏中 11β-羟类固醇脱氢酶 2 表达降低可能导致尼古丁/吸烟引起的小鼠血压升高。
Hypertension. 2021 Jun;77(6):1940-1952. doi: 10.1161/HYPERTENSIONAHA.120.16458. Epub 2021 Apr 5.
9
11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.11β-羟甾体脱氢酶:一个不断壮大的多功能家族。
Mol Cell Endocrinol. 2021 Apr 15;526:111210. doi: 10.1016/j.mce.2021.111210. Epub 2021 Feb 17.
10
Overview of Monogenic Forms of Hypertension Combined With Hypokalemia.单基因形式高血压合并低钾血症概述
Front Pediatr. 2021 Jan 25;8:543309. doi: 10.3389/fped.2020.543309. eCollection 2020.